Latest XTLB reports update at 2024-05-14: 2022 ∙ 2021 ∙ 2020

XTL Biopharmaceuticals Ltd. XTLB

$ 2.4 0.0%

XTL Biopharmaceuticals Ltd. Balance Sheet 2011-2024 | XTLB

Annual Balance Sheet XTL Biopharmaceuticals Ltd.

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-	-3.29 M	-2.02 M	-3.82 M	-2.16 M	-2.89 M	-3.31 M	-123 K
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	2.67 M	-	-	-	11 K	13 K	-
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	254 K	232 K	253 K	2.97 M	330 K	436 K	965 K	1.23 M	11.1 M	629 K
Deferred Revenue	-	-	-	-	-	-	-	-	-	35 K	-	-
Retained Earnings	-	-	-155 M	-154 M	-153 M	-156 M	-155 M	-152 M	-148 M	-146 M	-144 M	-143 M
Total Assets	4.19 M	6.62 M	6.5 M	7.21 M	8.58 M	6.59 M	3.02 M	5.32 M	5.64 M	8.02 M	11.1 M	4.07 M
Cash and Cash Equivalents	2.09 M	2.97 M	3.63 M	4.46 M	3.26 M	3.29 M	2.02 M	3.82 M	-	-	-	-
Book Value	-	6.62 M	6.25 M	6.98 M	8.32 M	3.62 M	2.69 M	4.89 M	4.68 M	6.78 M	-	3.44 M
Total Shareholders Equity	-	-	3.61 M	6.52 M	7.27 M	3.62 M	2.69 M	4.89 M	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet XTL Biopharmaceuticals Ltd.

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-155 M	-	-156 M	-	-156 M	-	-	-	-153 M	-	-	-	-153 M	-	-	-	-156 M	-	-	-	-155 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	6.62 M	-	6.95 M	-	6.5 M	-	-	-	7.21 M	-	-	-	8.58 M	-	-	-	6.59 M	-	-	-	3.02 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	2.97 M	-	2.92 M	-	3.63 M	-	4.03 M	-	4.46 M	-	-	-	3.26 M	-	-	-	3.29 M	-	-	-	2.02 M	-	-	-	3.82 M	-	-	-	2.16 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	6.62 M	-	6.95 M	-	6.5 M	-	-	-	7.21 M	-	-	-	8.58 M	-	-	-	6.59 M	-	-	-	3.02 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	5.33 M	-	3.28 M	4.37 M	3.61 M	-	5.6 M	6.71 M	6.52 M	-	-	-	7.27 M	-	-	-	3.62 M	-	-	-	2.69 M	-	-	-	4.89 M	-	-	-	4.68 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency